ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Kin And Carta Plc

Kin And Carta Plc (KCT)

129.60
0.00
(0.00%)
Closed July 16 11:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
129.60
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
59.00 52 Week Range 137.00
Market Cap
Previous Close
129.60
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
440,967
Shares Outstanding
177,931,360
Dividend Yield
-
PE Ratio
-12.28
Earnings Per Share (EPS)
-0.11
Revenue
195.87M
Net Profit
-18.77M

About Kin And Carta Plc

Sector
Commercial Printing, Nec
Industry
Printing,publishing & Allied
Headquarters
London, Gbr
Founded
1981
Kin And Carta Plc is listed in the Commercial Printing sector of the London Stock Exchange with ticker KCT. The last closing price for Kin And Carta was 129.60p. Over the last year, Kin And Carta shares have traded in a share price range of 59.00p to 137.00p.

Kin And Carta currently has 177,931,360 shares outstanding. The market capitalization of Kin And Carta is £230.60 million. Kin And Carta has a price to earnings ratio (PE ratio) of -12.28.

KCT Latest News

Official List Removal - KIN AND CARTA PLC

Official List 29 April 2024   NOTICE OF REMOVAL OF LISTING FROM THE OFFICIAL LIST 29/04/2024 08:00 REMOVAL KIN AND CARTA PLC The Financial Conduct Authority ("the FCA") removes the securities...

London Stock Exchange Notice Cancellation - KIN AND CARTA PLC

London Stock Exchange Notice 29 April 2024   NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE   29/04/2024 - 08:00   At the request of the company the following...

Maven Investment Partners Ltd Form 8.3 - KIN & CARTA PLC

Maven Investment Partners Ltd 26 April 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule...

BNP Paribas London Form 8.3 - Kin and Carta plc

BNP Paribas London 26 April 2024   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code...

Barclays PLC Form 8.3 - Kin and Carta plc

Barclays PLC 26 April 2024   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover...

Peel Hunt LLP Form 8.5 (EPT/RI) - Kin and Carta PLC

Peel Hunt LLP 26 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of...

Numis Securities Limited Form 8.5 (EPT/RI) - Kin & Carta Plc

Numis Securities Limited 26 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

Societe Generale SA Form 8.3 - Kin and Carta plc

Societe Generale SA 26 April 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
1200129.6129.8129.4440967129.6DE
26-5-3.7147102526134.6137125.22068822128.7084991DE
5266.3104.73933649363.3137591765376115.72400587DE
156-132.4-50.53435114526235955.2780586144.41357276DE
26024.623.428571428610535946627138135.76270254DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMIXAutonomix Medical Inc
$ 1.3701
(121.70%)
154.81M
SHOTWSafety Shot Inc
$ 0.41
(115.79%)
7.56k
DATSDatChat Inc
$ 1.89
(81.73%)
54.75M
CYNCYNGN Inc
$ 9.18
(53.77%)
17.79M
SCNIScinai Immunotherapeutics Ltd
$ 5.80
(42.86%)
29.37M
ASLNASLAN Pharmaceuticals Ltd
$ 1.36
(-46.67%)
1.16M
KZIAKazia Therapeutics Ltd
$ 0.5593
(-37.56%)
15.34M
LCFYLocafy Ltd
$ 3.5597
(-36.32%)
584.38k
NAASNaaS Technology Inc
$ 2.82
(-33.02%)
1.94M
ZENVZenvia Inc
$ 1.67
(-26.75%)
658.26k
FFIEFaraday Future Intelligent Electric Inc
$ 0.5152
(22.09%)
217.92M
NVDANVIDIA Corporation
$ 128.44
(-0.62%)
208.32M
SQQQProShares UltraPro Short QQQ
$ 7.46
(-0.67%)
155.14M
AMIXAutonomix Medical Inc
$ 1.3701
(121.70%)
154.81M
TSLATesla Inc
$ 252.64
(1.78%)
147.31M

Discussion

View Full Feed
Wise Man Wise Man 6 minutes ago
Correction: Separate Account Phase 2, only the NWS_dividend, not both.
to continue the Separate Account plan, now for their Recapitalization (through the Phase 2: 10% and NWS dividends, and phase 3: SPS LP increased for free)
As seen in this image showing the different styles Sandra T
FNMA
littlejohn littlejohn 10 minutes ago
Oil price down overnight isn't likely due

to any rah-rah politico sentiment...

More probable in anticipation of some

building inventories last week...

Limited export activity could cause pressure

from the liquids not moving a
PickStocks PickStocks 17 minutes ago
That would be awesome as it would be an opportunity to buy more as it goes up again
COOP
PickStocks PickStocks 19 minutes ago
Yes…and he also said real soon months ago
COOP
Fdc4 Fdc4 27 minutes ago
I guess you are about to have some proof of your own by now. Ouch… Averaging down now, right? Buying the cheapies
IGPK
GVInvestments GVInvestments 29 minutes ago
I'm holding till $300.00 per share.
FNMA
HippyTrades HippyTrades 29 minutes ago
Your head is literally spinning because you know that was a horrible annual report and you can't face it
AXXA
vinmantoo vinmantoo 32 minutes ago
No data on clinical endpoints.

Thanks for the link. Pretty telling that they didn't include symptom relief data.
HippyTrades HippyTrades 32 minutes ago
The buyback fund?
Wow do you ever make stuff up.
What do you think a disclosure is?
AXXA
DocLee DocLee 34 minutes ago
In "Nature", (12th July) another effective treatment (Car-T) for brain tumours (this time in children) which might complement DCVax (and would be less toxic). The article is at https://www.nature.com/articles/d41586-024-02255-2?utm_source=Live+Audience&utm_campaign=f8586bf0ce-nature-briefing-daily
NWBO
Wise Man Wise Man 39 minutes ago
Error in the hyperlink to the CFR 1229.13 posted before, that inserted a new capital distribution: the Lamberth rebate (Number 3), thanks to an express grant of authority of FHFA in the law to do it (Number 3 in the FHEFSSA definition of capital distribution, posted before).
Chevron deference
FNMA
nowwhat2 nowwhat2 42 minutes ago
1 HR LATER.......


https://investorshub.advfn.com/uimage/uploads/2024/7/16/qtmkceth_777_15_5d_945pm_chan_3500_Gee.jpg

1 HR LATER.......WHUMP !
https://investorshub.advfn.com/uimage/uploads/2024/7/16/facjveth_777_15_5d_1045pm_chan_3500_WHUMP.jpg
BTCUSD
nowwhat2 nowwhat2 43 minutes ago
1 HR LATER.......


https://investorshub.advfn.com/uimage/uploads/2024/7/16/qtmkceth_777_15_5d_945pm_chan_3500_Gee.jpg

1 HR LATER.......WHUMP !
https://investorshub.advfn.com/uimage/uploads/2024/7/16/facjveth_777_15_5d_1045pm_chan_3500_WHUMP.jpg
ETHUSD
Sltan Sltan 45 minutes ago
100X
RNVA
Sltan Sltan 46 minutes ago
I hope we see
0.01
Earnings results
Fusion
to divide
Million profits
Price 0.0001
Chance of achieving x100
🤑🤑🤑🤑🤑🤑
RNVA
sentiment_stocks sentiment_stocks 51 minutes ago
And if your feeling particularly brave, why not contact the Chair of the CHM ?..

p.mulholland@ucl.ac.uk

You know that it was Paul Mullholland who presented the DCVax-L P3 data results at New York Academy of Sciences in about an hour long presentation on May 20, 2023, ri
NWBO
cootcat cootcat 53 minutes ago
60f1 you just show up to let us know this is a scam. ARE you new or just a different name? But you are not the first to make that statement or that claim. One has to remember that this is micro penny stock. How many micro pennies stock are call scams and actual are?
ILUS
rikkie rikkie 56 minutes ago
Calimero !
LWLG
BugStrong BugStrong 59 minutes ago
Today we shall see how the flow is.
WDLF
LazyInvestor LazyInvestor 1 hour ago
What do you mean? The only financial records they needed to be current were for the 10Q for Q1 which were due in May. Or am I missing something here?
BEGI
BugStrong BugStrong 1 hour ago
I thought more info on the companies in the incubator would have been talked, more details.
WDLF
Louinjaxxx Louinjaxxx 1 hour ago
Maybe you don't want the company to audit the lndustries the company is involved in because it could make the company a great find in OTCMarkets.

Maybe you don't like how the CEO is managing the company because you think you could do better (CEO- envy).
AXXA
Wise Man Wise Man 1 hour ago
Summary of the current state of Fanniegate: Chevron deference🆚Rogues.

Justice Alito can't make laws. What he was doing with his opinion, was to endorse the Separate Account plan, whether he likes it or not. His spin isn't even taken into consideration: "Rehabilitate FnF in a w
FNMA
Twister Twister 1 hour ago
Military AR perhaps brighter than events/delays have appeared!

Delayed acceptance, budgets and depth of product scope remain attractive.
Corporate belt tightening is very real and military training budget cuts likely to continue.

Seeing continued interest by othe
VTSI
Fdc4 Fdc4 1 hour ago
I wouldn’t be surprised if it is higher. JFHE posted Q2 coming and strong. So, it shall be higher at least. What I don’t understand is why name change is taking too long
IGPK